Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD

Blood (2017) 130 (Supplement 1): 5173.

https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173

Published: 2017

Journal Articles

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Tuncay Aslan, Evren Ozdemir, MD, Aysegul Uner, Elif Gungor, Nevin Alayvaz Aslan, Esra Yildizhan, MD, Abdullah Agit, Serdal Korkmaz, MD, Gulsum Akgun Cagliyan, Ibrahim Barista, MD, Esra Ozhamam, Gulsum Emel Pamuk, MD, Mehmet Turgut, MD PhD, Bulent Eser, Gulsum Ozet, MD, Rahsan Yıldırım, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5332.

https://doi.org/10.1182/blood.V128.22.5332.5332

Published: 2016

Journal Articles

Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma

Alma Aslan, MD, Alev Turker, MD, Ayse Kars, MD, Ibrahim Barista, MD, Evren Ozdemir, MD

Blood (2016) 128 (22): 5390.

https://doi.org/10.1182/blood.V128.22.5390.5390

Published: 2016

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation

Evren Ozdemir, MD, Alma Aslan, MD, Alev Turker, MD, Ibrahim Barista, MD, Ayse Kars, MD

Blood (2015) 126 (23): 5090.

https://doi.org/10.1182/blood.V126.23.5090.5090

Published: 2015

Journal Articles

Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

Evren Ozdemir, MD, Alma Aslan, MD, Alev Turker, MD, Ibrahim Barista, MD, Ayse Kars, MD

Blood (2015) 126 (23): 1517.

https://doi.org/10.1182/blood.V126.23.1517.1517

Published: 2015

Journal Articles

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Hakan Goker, MD, Eylem Eliacik, MD, Fevzi Altuntas, MD, Emre Tekgunduz, MD, Evren Ozdemir, MD, Ayse Isik, MD, Omur Kayikci, MD, Ali Hakan Kaya, MD, Salih Aksu, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Haluk Demiroglu, Osman Ilhami Ozcebe, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5830.

https://doi.org/10.1182/blood.V124.21.5830.5830

Published: 2014

Journal Articles

Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.

Evren Ozdemir, MD, Yener Koc, MD, Ayse Kars, MD, Alev Turker, MD, Gulten Tekuzman, MD, Emin Kansu, MD

Blood (2007) 110 (11): 4810.

https://doi.org/10.1182/blood.V110.11.4810.4810

Published: 2007

Journal Articles

CMV Reactivation after Allogeneic Stem Cell Transplantation Is Associated with a Preponderance of Circulating Late-Stage CMV-Specific CD8+ T Cells.

Krishna V. Komanduri, MD, Lisa S. St. John, PhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Jeffrey J. Molldrem, MD, Evren Ozdemir, MD

Blood (2005) 106 (11): 3250.

https://doi.org/10.1182/blood.V106.11.3250.3250

Published: 2005

Journal Articles

High-Dose Sequential Chemotherapy (HDSC) in Support of Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).

Basak Oyan, MD, Yener Koc, MD, Evren Ozdemir, MD, Emin Kansu, MD

Blood (2004) 104 (11): 5231.

https://doi.org/10.1182/blood.V104.11.5231.5231

Published: 2004

Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience.

Yener Koc, MD, Evren Ozdemir, MD, Basak Oyan, MD, Emin Kansu, MD

Blood (2004) 104 (11): 5155.

https://doi.org/10.1182/blood.V104.11.5155.5155

Published: 2004

NARROW

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation

Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Bortezomib, Dexamethasone and Concomitant or Sequential Thalidomide (VTD): An Effective Combination for Relapsed/Refractory Multiple Myeloma Failing Thalidomide and Dexamethasone.

CMV Reactivation after Allogeneic Stem Cell Transplantation Is Associated with a Preponderance of Circulating Late-Stage CMV-Specific CD8+ T Cells.

High-Dose Sequential Chemotherapy (HDSC) in Support of Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed/Refractory Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).

Nonmyeloablative Allogeneic Stem Cell Transplantation: Hacettepe University Institute of Oncology Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only